Paladin Capital Group led the Series A round with participation from Osage University Partners, Brighteye Ventures, and Marathon Venture Capital.
"We are delighted with our growth and community support but we are most proud of having created a platform that turns ethical hacking into a true passion. Everything we do is geared around creating a safer Internet by empowering corporate teams and individuals to create resilient systems. Hack The Box is proud to train the world’s best"
The financing round was led by Vulpes Investment Management with backing from existing investors to fund first in-human data acquisition.
"The current device market for brain aneurysms is valued at well over $1bn and is growing rapidly year-on-year. One of the biggest challenges when it comes to treating neurovascular disease is having devices with high efficacy whilst minimising adverse events. Studies show that often multiple attempts are made to place treatment devices, as they often have challenges of landing accurately, opening and maintaining position. This can lead to adverse events and multiple devices being used. Procedures typically cost over $50,000 to treat a brain aneurysm and a next generation flow diverter overcoming unmet needs, offers the chance for more effective, safer and cost effective treatments as well as allowing many more patients to benefit. We plan to use this funding to bring Oxford Endovascular’s ground-breaking technology to the next stage and gain clinical data from human studies."
Companyon Ventures led the Series A round to accelerate product development and customer initiatives.
"With support from Companyon Ventures and Riverside Acceleration Capital, Ziflow is primed to enter its next chapter of growth and achieve its vision of helping teams review and approve content, regardless of type, device or workflow"